Avik Banerjee is an expert in Biochemistry at Immune-Onc Therapeutics (United States). Avik Banerjee has authored 32 publications, the most recent in 2021, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 88 (community average: 125). How the SLR is computed.

LeadR Profile

Avik Banerjee Immune-Onc Therapeutics United States
88 ScienceLeadR Reputation 88
Network Map

Biochemistry

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2023

Source: PubMed

Immune Onc Therapeutics

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 32

Citations

Citations: 1 456 1st author: 10 Last author: 2 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
PMID 34194396 — thyroid cancer, papillary, disease management, neoplasms, cohort studies, thyroid gland, thyroid neoplasms, therapeutics, thyroidectomy, endocrine system diseases
Front Endocrinol (Lausanne)202112
Ultrasound in active surveillance for low-risk papillary thyroid cancer: imaging considerations in case selection and disease surveillance.
PMID 34529219 — risk, research design, thyroid neoplasms, disease progression, thyroid gland, thyroid cancer, papillary
Insights Imaging202112
A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
PMID 32126932 — trust, thyroid cancer, papillary, disease management, thyroid diseases, neoplasms, thyroid gland, decision making, health personnel, thyroid neoplasms, thyroidectomy, thyroid hormones
Thyroid202066
Response to Miyauchi re: "A Prospective Mixed-Methods Study of Decision Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer".
PMID 32560596 — risk, thyroid hormones, decision making, thyroid neoplasms, thyroid gland, thyroid diseases, thyroid cancer, papillary
Thyroid20200
NMR resonance assignment and structure prediction of the C-terminal domain of the microtubule end-binding protein 3.
PMID 32421702 — microtubules
PLoS One20202

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Active not recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
NCT04624477 — thyroid cancer, papillary, disease management, neoplasms, thyroid gland, thyroid neoplasms, thyroidectomy, carcinoma
N/AActive not recruiting2021

LeadR Networks

Main global connection map